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Hyaluronic acid (HA) is a ubiquitous biopolymer involved in many pathophysiological
roles. One HA receptor, the cluster of differentiation CD44 protein, is often overexpressed
in tumor cells. As such, HA has attracted considerable interest in the development of drug
delivery formulations, given its intrinsic targetability toward CD44 overexpressing cells.
The present study is focused on examining the correlation of HA molecular weight with
its targetability properties. A library of conjugates obtained by linking the amino group
of the phospholipid 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE) to the
carboxylic residues of HA of different molecular weight (6.4, 17, 51, 200, and 1,500 kDa)
were synthesized and fully characterized. The HA-DMPE conjugates were then used
to non-covalently functionalize the highly hydrophobic single-walled carbon nanotubes
(CNT), and further encapsulate the anticancer drug doxorubicin (DOX). Our results show
that the complexes DOX/CNT/HA-DMPE maintain very good and stable dispersibility.
Drug release studies indicated a pH-responsive release of the drug from the nanocarrier.
Cell viability tests demonstrated that all HA modified CNTs have good biocompatibility,
and specific targeting toward cells overexpressing the CD44 receptor. Among all the
molecular weights tested, the 200 kDa HA showed the highest increase in cellular uptake
and cytotoxic activity. All these promising attributes make CNT/HA200-DMPE a “smart”
platform for tumor-targeted delivery of anticancer agents.
Keywords: carbon nanotubes, hyaluronic acid, targeted drug delivery, cancer, phospholipids, CD44 receptor,
nanocarrier
INTRODUCTION
Hyaluronic acid (HA) is a linear polysaccharide consisting of repeating β-1,4-D-glucuronic acid
and β-1,3-N-acetyl-D-glucosamine disaccharide units. The disaccharide unit can repeat thousands
of times, achieving high molecular weights (MW) of over 5,000 kDa. HA represents the main
component of the extracellular matrix and is ubiquitously distributed in vertebrate tissues. In the
human body, predominantly in the skin, the total HA is about 15 g, with a rapid daily turnover
achieved through the activity of hyaluronidases (Stern, 2004). Regarding the HA physiologic role,
it plays both a structural role, for example, in the skin due to unique hydrodynamic properties, as
well as cell signaling role, for example, during the dynamic cell processes of morphogenesis and
inflammation. A large amount of HA in the extracellular matrix of the central nervous system
contributes to brain hydration (Perkins et al., 2017). In the lungs, it contributes to the mechanical
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properties of tissues, such as elasticity, while in the cardiovascular
system, HA is involved in several pathophysiological conditions
(Fischer, 2019).
To exert its biological properties, HA requires specific
interactions with several cell receptors, such as CD44, RHAMM,
HARE, and LYVE-1, to trigger specific signaling pathways
inside cells. The more representative cell-binding receptor
of HA is the cluster of differentiation protein CD44. The
interaction of HA with this protein is involved in physiological
and pathological processes, particularly in repair mechanisms.
Nevertheless, the CD44 receptor is also associated with human
cancer, particularly during tumor invasion andmetastasis (Toole,
2009). Different therapeutic treatments exploit HA, such as in
regenerative, aesthetic, and orthopedic medicine. Due to its
intrinsic properties, HA attracts interest in the development
of drug delivery agents (Dosio et al., 2016; Passi and Vigetti,
2019). This natural polymer combines useful aspects suitable for
a drug delivery nanocarrier, such as its high-water solubility,
non-immunogenicity, biocompatibility, and biodegradability.
Furthermore, the functional groups of HA can be easily
modified by chemical reactions as its structure is based on the
presence of β linkages, which allow for the bulky groups (the
hydroxyls, the carboxylate moiety, and the anomeric carbon
on the adjacent sugar) to be in sterically favorable equatorial
positions. As such, HA can be easily functionalized with other
materials, inferring new properties, and improving the existing
aspects of the biopolymer. For instance, fluorescence properties
can be introduced to HA by functionalizing the polymer with a
fluorophore tag. HA could also be used to functionalize carbon
nanoparticles, improving their dispersibility properties (d’Amora
et al., 2020).Moreover, by exploiting specific enzymatic reactions,
HA with precise different molecular weight and properties can be
obtained (Valcarcel et al., 2020).
Among the inorganic nanomaterials, carbonaceous
nanomaterials are attracting interest due to their excellent
mechanical, thermal, and optical properties. Their inert
composition is highly beneficial, making them biocompatible
and thus highly desirable for biological applications, although
with poor aqueous dispersibility (Saleem et al., 2018). Among
the carbon-based materials, the nanotubes (CNTs) (Movia
and Giordani, 2012; Chen et al., 2017; Mahajan et al., 2018)
have demonstrated biocompatibility and they possess a hollow
construction and tunable chemistry that provide interesting
opportunities for use as delivery systems. The drugs can be
loaded onto the CNT surface by a covalent bond, through
a cleavable linker or complexation via π-π interactions and
adsorption of charged surfactants (Szleifer and Yerushalmi-
Rozen, 2005). Many anticancer drugs have been linked with
CNTs, such as epirubicin, doxorubicin, methotrexate, quercetin,
paclitaxel, gemcitabine, irinotecan, and porphyrins (Bianco
et al., 2008; Wong et al., 2013). In an attempt to reduce the high
aggregation tendency of pristine CNTs and to improve water and
biological media dispersibility, several coating strategies have
been developed. From collagen to proteins, polymers, pegylated
lipids, and block copolymers have shown to serve as excellent
wrapping materials for the non-covalent functionalization of
CNTs as a result of π-π stacking and van der Waals interactions.
Among these wrapping strategies, HA has demonstrated very
beneficial results in dispersing CNTs loaded with doxorubicin
(Datir et al., 2012; Cao et al., 2015) and gemcitabine (Prajapati
et al., 2019). Given the aforementioned modifiability of the
polymer, HA can be coupled to various surfactants, such as 1,2-
dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE), which
could further improve its dispersibility properties, allowing for
increased dispersion of CNTs (Di Crescenzo et al., 2011a,b).
It has been found that the MW of HA regulates its diverse
physio-pathological functions (Misra et al., 2015). A similar
relationship has also been observed in nanostructures decorated
with HA, where MW affected the targeting efficiency; the impact
of HA MW on grafted liposomes have been reported by several
authors (Arpicco et al., 2013; Mizrahy et al., 2014; Qhattal et al.,
2014; Zhong et al., 2019) where the liposomal cellular uptake
was improved with increasing of HA MW (5–8 < 10–12 < 175–
350 kDa). Consequently, improved cytotoxic and in vivo activity
against cancer models have been observed. Li et al. demonstrated
that iron oxide nanoparticles coated with 31 kDa HA showed a
better targeting ability than lower MW (Li et al., 2014).
Nevertheless, a systematic evaluation of the role of HA MW
in increasing dispersibility and imposing targeting activity on
CNTs has not yet been investigated. In the present study, we
investigate the relationship of HA MW on dispersibility and
specific targeting effect of functionalized CNTs, in order to
provide a useful guideline for designing similar and other carbon-
based HA-decorated nanostructures.
Based on our previous studies, HA-phospholipids
conjugates made with five different MW HA were prepared
and characterized. Exploiting the strong interaction of
phospholipid acyl chains with the surface of CNTs, stable
and dispersible derivatives have been obtained. Then, the
cationic anthracycline antibiotic doxorubicin was loaded onto
the nanotubes via a π-π stacking interaction. Furthermore,
the different nanostructures have been investigated for their
physiochemical and pharmaceutical properties, evaluating their




Single-walled carbon nanotubes (CNTs), 100–1,000 nm in length




phosphoethanolamine (DMPE) and 1,2-dipalmitoyl-sn-glycero-
3-phosphoethanolamine (DPPE) were provided by Avanti Polar
Lipids, distributed by Sigma-Aldrich S.r.l. (Milan, Italy).
Sodium Hyaluronate
Sodium hyaluronate (HA) of different molecular weights: 6.4 kDa
(HA6.4), 17 kDa (HA17), 51 kDa (HA51), 200 kDa (HA200), and
1,500 kDa (HA1500), was purchased from Lifecore Biomedical
(MN, USA).
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Other
Doxorubicin (DOX) hydrochloride was purchased from APAC
Pharmaceutical (MD, USA). Fluoresceinamine, isomer I, 1-
ethyl-3-[3-(dimethylamino)-propyl]-carbodiimide (EDAC),
Fetal Bovine Serum (FBS), Dulbecco’s Modified Eagle Medium
(DMEM), Roswell Park Memorial Institute (RPMI) 1640
Medium, and all other chemicals, cell culture media, and
supplements were sourced from Sigma-Aldrich S.r.l.
Synthesis and Functionalization
Preparation of HA-DMPE and HA-DPPE
The HA-DMPE and HA-DPPE conjugates were prepared
following our previously described method (Surace et al., 2009),
with slight modifications. Briefly, a mixture of 20mg of HA and
10mg of EDAC was dissolved in 5mL of distilled water. The pH
was adjusted to 4 with 0.1N HCl, and the solution was stirred
for 2 h at 37◦C. The activated HA was then added to a lipid film
of DMPE or DPPE (the phospholipid molar excess was ×25 for
HA6.4, HA17, and HA51; ×50 for HA200; and ×70 for HA1500).
The pH was adjusted to 8.4 with a 0.1M borate buffer (pH 9.5),
and the suspension was sonicated at 37 kHz for 30min. The
mixture was stirred for 24 h at 37◦C and then centrifuged at
6,000 rpm for 10min. The precipitate was eliminated, and the
supernatant was collected and purified by dialysis for 48 h at 4◦C
against distilled water using a Spectra/Por R© regenerated cellulose
membrane (Spectrum, Breda, The Netherlands) with molecular
cut-off (MWCO) of 3,500 Da (for HA6.4) and 12,000–14,000 Da
(for remaining HA MWs) to remove unreacted phospholipids,
EDAC, and other by-products. The conjugation reactions were
monitored by thin-layer chromatography (TLC) on F245 silica
gel pre-coated sheets (Merck, Milan, Italy). The purification
was confirmed by TLC using chloroform/methanol (70:30 v/v);
after migration of the mobile phase, the sheets were exposed to
iodine vapors, a solution of molybdenum blue, and ninhydrin
(2,2-dihydroxyindene-1,3-dione) solution (2% in ethanol). The
conjugates were lyophilized and analyzed by 1Hnuclearmagnetic
resonance (1H-NMR). The amount of phospholipid linked to
HA in the different conjugates was quantified after resuspension
in distilled water by a phosphate assay after disruption with
perchloric acid (Bartlett, 1959).
Preparation of f-HA and f-HA-DMPE
Labeling of HA with fluoresceinamine (f-HA) was carried
out as previously described, with minor modifications (de la
Fuente et al., 2008). Briefly, a solution composed of 12.5mg of
fluoresceinamine in 0.25mL of DMSO, 12.5 µL of acetaldehyde
and 12.5 µL of cyclohexyl isocyanide was added to a solution
of 25mg HA in 20mL of deionized water and 20mL of DMSO,
and the pH was adjusted to 4.5 with 0.1N HCl. Then, the
reaction was stirred at room temperature in darkness for 12 h.
The f-HA was precipitated with a saturated solution of NaCl
and ice-cold ethanol, collected by centrifugation, suspended in
and extensively dialyzed against deionized water, lyophilized, and
stored at −20◦C in the dark before use. The f-HA was used
to prepare f-HA-DMPE following the same procedure described
for the preparation of HA-DMPE. Fluoresceinamine labeled HA-
DMPE conjugates were used to functionalize CNT for the further
cellular uptake experiments.
Preparation of DOX/CNT and DOX/CNT/HA-DMPE
DOX was non-covalently loaded onto the CNT and CNT/HA-
DMPE to make DOX/CNT and DOX/CNT/HA-DMPE,
respectively. In this regard, 1mg of CNTs were suspended in
2mL of the different MW HA-DMPE conjugates solutions (1
mg/mL in PBS pH 7.4) and bath sonicated for 3 h. Then, a
range of 0.5–1.5mL of DOX solutions (1 mg/mL in PBS pH
7.4) was added in order to determine the appropriate amount of
drug that can be loaded onto the CNT. The mixture was then
bath sonicated for 2 h at 37◦C and the DOX/CNT/HA-DMPE
were purified by repeated filtering and washing with PBS
(Centrisart R© I, MWCO 100 kDa, Sigma-Aldrich) to remove the
unbound products. To remove the excess HA-phospholipids
obtained starting from HA200 and HA1500, the suspension
was centrifuged at 11,000 rpm for 30min, and the pellet was
recovered. The amount of unloaded DOX was quantified
by measuring the absorbance of the supernatants at 480 nm
(Beckman 730 spectrophotometer Beckman Coulter, Milan,
Italy). The percentage of HA associated with the CNTs was
determined by the carbazole assay (Bitter and Muir, 1962).
Chemico-Physical Characterization
Nuclear Magnetic Resonance
1H nuclear magnetic resonance (NMR) spectra were recorded
on a Bruker Avance 300 spectrometer (Karlsruhe, Germany)
operating at 7T. Samples were dissolved in D2O.
Transmission Electron Microscopy
Transmission electron microscopy (TEM) images were recorded
with a JEM 3010 ultrahigh-resolution analytical electron
microscope (JOEL) at an accelerating voltage of 300 kV. TEM
grids were prepared by spreading a droplet of the sample
solution in deionized water on a copper grid coated with a lacey
carbon film.
Thermogravimetric Analysis
Thermal gravimetric analysis (TGA) was carried out on a TGA
4000 System (PerkinElmer, Waltham, MA, USA). The sample
was heated in argon from 50 to 800◦C at a rate of 10◦C/min.
Zeta Potential
The zeta potential (ZP) of all materials was investigated using a
Nanosizer Nano Z (Malvern, UK). Measurements were taken in
triplicate at 25◦C, and the Smoluchowski equation was applied.
UV-Vis Absorption Spectroscopy
Absorption spectroscopy analyses were performed on a
Shimadzu UV-1800 spectrophotometer using 1 cm path-length
quartz cuvettes. Solutions at 1 mg/mL of all the analyzed samples
(DOX, HA-DMPE and DOX/CNT/HA-DMPE) were diluted in
deionized water to achieve a final concentration of 100µg/mL.
After sonication for 15min at 37 kHz, solutions at 10, 20, and
50µg/mL were prepared for the analyses.
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FIGURE 1 | Schematic representation of the preparation of the HA-DMPE conjugate. The preparation of the HA-DPPE conjugate follows an identical procedure, with
the exception that DPPE is used instead of DMPE.
Fluorescence Spectroscopy
Fluorescence spectroscopy analyses were conducted on an LS-
55 spectrofluorometer (PerkinElmer). Sample solutions were
prepared at 1 mg/mL and diluted in deionized water to achieve
a final concentration of 100µg/mL. After sonicating the sample
for 15min at 37 kHz, 10 and 20µg/mL solutions were prepared
for the analysis.
Stability Studies
The stability of DOX/CNT and DOX/CNT/HA-DMPE at
different HA MW was assessed in different biological media.
The media used to perform this experiment were commercially
available, and included: deionized water, PBS, RPMI 1640,
1640 + 10% FBS, DMEM, and DMEM + 10% FBS, For each
nanomaterial, 1mg was dispersed in 2mL of each medium
(500µg/mL) by sonicating at 37 kHz for 1 h. The dispersions
were photographed immediately after sonication, and then kept
at 4◦C for 3 months, at which point they were photographed
again. A 1:10 dilution (50µg/mL) was also prepared and the
stability was evaluated over 25 days period.
Drug Release Studies
The in vitro DOX release from the CNT/HA-DMPE materials
was evaluated at 37◦C in PBS (pH 7.4) and acetate buffer (pH 5.5)
by the dialysis method. Four milligram of each DOX/CNT/HA-
DMPE material (HA MW 6.4, 17, 51, 200, and 1,500) was
dispersed in 4mL of PBS and transferred into dialysis bags
(MWCO 3,500 Da) that were immersed in 35mL of the release
medium. At predetermined time intervals (0, 1, 3, 5, 24, 48,
72 h), 1mL was taken and analyzed by UV-Vis spectroscopy to
determine the amount of released DOX. The solution abstracted
for UV-Vis analysis was immediately replaced with an equal
volume of fresh medium.
Biological Studies
Tumor Cell Lines and Cell Culture
The cell lines used were MDA-MB-231 (human breast
adenocarcinoma) and A2780 (human ovarian carcinoma).
MDA-MB-231 cells were grown in DMEM supplemented with
10% FBS, 0.03% L-glutamine, 2% penicillin and streptomycin.
A2780 cells were maintained in RPMI 1640 containing 10%
FBS, 0.03% of L-glutamine, 2% penicillin and streptomycin,
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FIGURE 2 | The non-covalent approach for the functionalization of CNTs with
the HA-DMPE conjugate (orange helix) and DOX (red) to make a
DOX/CNT/HA-DMPE system.
and 50µg/mL of gentamicin sulfate. Cells were maintained in a
humidified incubator at 37◦C in 5% CO2.
Cellular Uptake
A quantitative analysis of CNT/f-HA-DMPE cellular uptake
was carried out on a C6 Flow Cytometer System (AccuriTM
Cytometers, Milan, Italy). Briefly, MDA-MB-231 and A2780
cells were plated in 6-well culture plates (5 × 105 cells/well)
and incubated with CNT/f-HA-DMPE (10µg/mL in PBS) for
3 and 24 h. Cells were washed twice with PBS, detached
after each incubation period using a 0.05% trypsin−0.02%
EDTA solution, and re-suspended in 500 µL PBS. They were
then run on the flow cytometer, which considered 10,000
events, using 488 nm excitation to measure the intracellular
CNT/f-HA-DMPE fluorescence (FL-1 channel, λex: 488 nm,
λem: 530 nm). Cell-associated fluorescence is expressed as
integrated mean fluorescence intensity (iMFI); the product
of the frequency of cells that are positive to CNT/f-HA-
DMPE and the mean fluorescence intensity of the cells. Results
are expressed as a ratio between the iMFI of treated and
untreated cells.
Cell Proliferation Assay
The effect on cell growth inhibition was evaluated by the
sulforhodamine B colorimetric proliferation assay (SRB)
modified by Vichai and Kirtikara (Vichai and Kirtikara, 2006).
MDA-MB-231 and A2780 cells, maintained in culture as
described above, were seeded at 3 × 104 cells/well in 96 wells
microtiter plates and incubated overnight to allow cellular
adhesion. Various dilutions of DOX/CNT/HA-DMPE (expressed
as drug concentration) and unloaded CNTs (expressed as CNTs




HA of different MW (6.4, 17, 51, 200, and 1,500 kDa)
was used to prepare a small library of conjugates with
DMPE. After purification and characterization, the
conjugates were used to functionalize CNTs with the aim
of increasing their water dispersibility and biocompatibility,
and to confer targeting ability toward CD44+ cells. The
linkage between phospholipids and HA was obtained
through amide formation mediated by the water-soluble
carbodiimide derivative EDAC (Figure 1). In these conjugates,
the phospholipid amino group is randomly linked to
the carboxylic residues of HA, as previously reported
(Surace et al., 2009; Cosco et al., 2017).
Conjugates were also prepared using DPPE instead of
DMPE. Both conjugates permitted the functionalization of CNTs,
confirming that the length of the phospholipid acyl chain does
not influence the CNTs modification, as previously observed
(Dvash et al., 2013). On the other hand, the different chemico-
physical characteristics of the two phospholipids affected the
reaction yield. Only the conjugates obtained with DMPE were
used for further studies since they contained a higher amount of
phospholipid linked to HA.
After purification by centrifugation and dialysis,
the conjugates were lyophilized; 1H-NMR analysis
(Supplementary Figure 1) confirmed the covalent linkage
between DMPE and HA of different MW as previously reported
(Cosco et al., 2017).
The amount of DMPE linked to HA was determined through
a phosphorus assay. The degree of substitution (DS = mol
DMPE/mol repeating unit× 100) ranged from 0.46 to 0.98%.
CNT/HA-DMPE systems were prepared through the non-
covalent functionalization of CNTs with HA-DMPE conjugates
of various HA MW. This improved the water dispersibility and
biocompatibility of the CNTs. Then, the cationic anthracycline
antibiotic DOX was loaded onto the CNT/HA-DMPE (Figure 2)
via a π-π stacking interactions between the aromatic DOX and
the sidewall of the CNTs, and van der Waals and hydrophobic
interactions (Datir et al., 2012; Mehra et al., 2014; Wang and Xu,
2015).
Thus, CNTs were added to PBS suspension of the previously
prepared HA-DMPE conjugates and sonicated for 3 h, then DOX
was added, and the mixture was sonicated for a further 2 h. We
preferred to add DOX in the second step of the reaction in order
to reduce the risk of drug degradation related to a prolonged
sonication time. The mixture was then purified by ultrafiltration
in order to remove the unbound compounds. We have observed
that a DOX: CNT/HA-DMPE ratio of 2:1 w/w allowed the
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FIGURE 3 | Representative TEM images at x300K magnification of pristine CNTs (left); CNT/HA200-DMPE (middle); and CNT/HA6.4-DMPE (right).
FIGURE 4 | TGA profiles of (A) CNT/HA-DMPE; (B) DOX/CNT/HA-DMPE; (C) HA; and (D) HA-DMPE analyzed at different chain lengths of HA, including 6.4, 17, 51,
200, and 1,500 kDa. The TGA profiles of CNT and DOX/CNT have been included in both (A,B) for reference.
complete drug loading in all the CNTs functionalized with
the different HA-phospholipid conjugates previously prepared.
On the other hand, when the amount of DOX was increased,
unbounded drug was recovered during ultrafiltration. There
was no linear correlation between the amount of unbounded
DOX and the MW of the HA-DMPE conjugate; only in
the case of non-functionalized CNTs, the amount of DOX
loaded was doubled; a similar behavior was also observed by
Yao et al. (2016).
A carbazole assay determined the quantity of HA non-
covalently bound to the CNTs, for all HA-functionalized CNT
materials. The results indicated that it was identical to the
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TABLE 1 | Zeta potential (ZP) values of the different functionalized CNTs.
Sample ZP ± S.D. (mV)
CNTs −18.8 ± 0.7
DOX/CNTs −8.6 ± 0.4
CNT/HA6.4-DMPE −21.4 ± 1.1
DOX/CNT/HA6.4-DMPE −2.91 ±1.0
CNT/HA17-DMPE −25.9 ± 1.2
DOX/CNT/HA17-DMPE −7.3 ± 1.4
CNT/HA51-DMPE −28.7 ± 1.9
DOX/CNT/HA51-DMPE −9.6 ± 1.0
CNT/HA200-DMPE −34.1 ± 0.7
DOX/CNT/HA200-DMPE −19.8 ± 1.0
CNT/HA1500-DMPE −48.3 ± 0.5
DOX/CNT/HA1500-DMPE −41.0 ± 0.9
quantity added in the functionalization reaction, meaning that




The structure and morphology of the functionalized CNTs
was analyzed by TEM. Representative TEM images of pristine
CNTs and CNT/HA-DMPE are depicted in Figure 3. The
graphitic structure of the nanotube is evident, indicating that
the process of coating CNTs with the HA-DMPE conjugate
does not affect the structural integrity of the nanomaterial.
The CNTs are clearly visualized. The polymeric material on
the CNT surface in the nanocarriers HA-DMPE cannot be
readily seen as it is in an amorphous form. Compared to
the pristine CNTs, the CNT/HA6.4-DMPE and CNT/HA200-
DMPE did not exhibit appreciable differences in morphology
or aggregation.
Thermogravimetric Analysis
TGA was used to characterize CNT, DOX/CNT, CNT/HA-
DMPE, and DOX/CNT/HA-DMPE, as well as HA-DMPE and
HA for comparative purposes (Figure 4).
Pristine CNTs show a typical, low weight loss, which is
associated with the defects and oxidized functional groups
present on the surface.
In contrast, CNT/HA-DMPE and DOX/CNT/HA-DMPE lost
a considerable amount of their weight, demonstrating the
success of surface functionalization with HA-DMPE and DOX.
Furthermore, the main stage of weight loss in CNT/HA-
DMPE and DOX/CNT/HA-DMPE occurs at an almost identical
temperature (270◦C) as observed for both HA and HA-DMPE,
with a small shift toward higher temperature for the conjugated
CNTs; a further indication of the correct derivatization.
Notably, DOX/CNT has a slightly-higher weight loss profile
than that of pristine CNTs, which can be ascribed to the
degradation of DOX non-covalently linked to CNTs surface.
In addition, thermogravimetric DOX/CNT/HA-DMPE profile
shows a significant more pronounced weight loss compared with
DOX/CNT ones. The presence of HA-DMPE on CNTs surface
may enhance the loading ability of the nanocarrier, probably
because of the additional interaction between polymeric chains
and DOX.
However, the interaction between CNT/HA-DMPE and DOX
to give DOX/CNT/HA-DMPE seems to occur by displacing some
HA-DMPE chains from the nanotube surface. The weight loss
of DOX/CNT/HA-DMPE is equal, or lower (depending from
HA size), than CNT/HA-DMPE, indicating that the interaction
between aromatic rings of DOX, the graphitic surface the CNT,
and the linked DMPE residue requires the displacement of some
hindering HA-DMPE chains on the particle outer layer.
Zeta Potential
Zeta potential (ZP) analysis (Table 1) confirmed the presence
of HA on the CNTs surface. The measured ZP has an inversely
proportional relationship with HA MW, decreasing as the MW
increases. This is due to the multiple carboxyl groups present on
HA. Moreover, when the positively charged DOX was added, the
zeta potential increased, indicating the successful adsorption of
the drug onto the nanotubes.
UV-Vis Absorption and Fluorescence Spectroscopy
The loading of DOX onto the CNT/HA-DMPE nanohybrids was
confirmed by UV-Vis and fluorescence spectroscopy analysis.
DOX has a characteristic absorption peak at 480 nm (Figure 5A);
given that HA-DMPE does not absorb in the visible region
(Figure 5B), the presence of a peak at 480 nm in DOX/CNT/HA-
DMPE (Figure 5C) confirms the presence of the drug in
the nanomaterial. Also, it is interesting to note that the Van
Hove singularities (Kim et al., 1999) of the CNT can be seen in
the absorption spectrum of DOX/CNT/HA-DMPE (Figure 5C).
These are points where the density of states (i.e., the number
of quantum states that electrons inside the system can take) is
not differentiable (Kataura et al., 1999; Ryabenko et al., 2004).
A number of these Van Hove singularities can be seen as
small features above 600 nm (Figure 5C). Their presence further
indicates that the intrinsic structure of the CNTs is not affected
by the loading of HA-DMPE and DOX.
From the absorption spectrum of DOX/CNT/HA-DMPE
(Figure 5C), it can also be concluded that 1,500 kDa HA is the
best of the five MWs analyzed for dispersing the nanomaterial, as
evidenced by the highest absorption of the nanomaterial across
the spectrum.
When excited by light in the blue-visible range, DOX
fluoresces due to its highly conjugated structure. The emission
profile of DOX (Figure 6) shows that, when excited at λex
480 nm, the anticancer drug emits at λmax 592 nm with the
strongest intensity. When the fluorescent DOX was adsorbed
on the surface of the nanomaterials, the fluorescence signal
decreased due to the proximal distance and energy transfer. The
emission spectra of the DOX/CNT/HA-DMPE nanocomposites
are shown in Figure 6 and confirm the successful loading of the
drug onto CNT/HA-DMPE.
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FIGURE 5 | UV-Vis absorption spectra in water of (A) DOX at various concentrations (10, 20 and 50µg/mL); (B) HA-DMPE (50µg/mL); and (C) DOX/CNT/HA-DMPE
(10µg/mL). Materials involving HA were analyzed at various chain lengths (6.4, 17, 51, 200, and 1,500 kDa).
Stability Studies
The modification of DOX/CNTs with HA-DMPE conjugates
of different MW significantly increased their water dispersity
and stability (Figure 7 and Supplementary Figure 2). The
DOX/CNT/HA-DMPE of different HA MW were well-dispersed
and stable without aggregation in different media for over 3
months. In contrast, DOX/CNT was not dispersible in any of the
tested media. The media chosen for this experiment were those
used for the cell lines culture. These results confirm that the HA-
DMPE conjugate imposes excellent dispersibility and stability
onto the CNT systems.
Drug Release Studies
The in vitro release profile of DOX from DOX/CNT/HA-
DMPE was investigated at 37◦C at two different pH values
(7.4 and 5.5), which represent the physiological condition and
acidic microenvironment of both tumor tissue and lysosomes,
respectively (Figure 8). We observed that the DOX release
rate is faster at pH 5.5 than at pH 7.4. After 72 h, at most,
around 20% of DOX was released at acidic pH, and only 5% of
DOX was released at physiological pH. The overall low DOX
release at both pH values is probably due to steric hindrance
and chain entanglement of the HA coating. Moreover, once
internalized into tumor cellsCNTs will further release DOX
in the acidic compartment of lysosomes, given the enhanced
hydrophilicity and solubility of DOX in low pH environments
(Wang and Xu, 2015).
As the pH was lowered, drug release was increased,
suggesting an endogenous pH-responsive mode of controlled
drug release. This means that DOX will be selectively released
in acidic microenvironments, such as that in tumors, while at
physiological pH, the drug will remain preferentially loaded on
the CNT surface. The increase of DOX release at low pH is
due to the partial protonation of DOX amino groups, which
increases its hydrophilicity and does not favor the π-π stacking
interactions between the drug and CNTs, facilitating a partial
DOX detachment from the carrier (Wong et al., 2013; Wang and
Xu, 2015).
The results (Figure 8) also presented a drug release
dependency on the MW of the HA-DMPE conjugate. The
highest drug release (about 7% at pH = 7.4 and 18% at
FIGURE 6 | Emission spectra in water at λex 480 nm of DOX (10µg/mL) and
DOX/CNT/HA-DMPE (20µg/mL) at various HA chain lengths (6.4, 17, 51,
200, and 1,500 kDa).
pH = 5.5) was observed for DOX/CNT/HA200-DMPE,
indicating that it is the ideal HA MW of the five investigated
variants. In the case of higher MW DOX/CNT/HA1500-
DMPE, a reduction of DOX release was observed. Given
that the amount of loaded drug is similar for all the
samples, this behavior could be attributed to the high




The HA receptor CD44, a ubiquitous transmembrane cell
surface protein, is expressed at low levels on the surface of
several normal cells and overexpressed in many cancer cells
(Sneath and Mangham, 1998). We have recently reported
that the MDA-MB-231 (human breast adenocarcinoma)
cells display high expression of CD44 and that the A2780
(human ovarian carcinoma) cells did not express a detectable
amount of CD44 (Ricci et al., 2018). Thus, to evaluate the
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FIGURE 7 | Representative images of DOX/CNT (left) and DOX/CNT/HA-DMPE (right) dispersion stability after 3 months at 4◦C in various biological fluids at a
concentration of 500µg/mL. Representative images are of DOX/CNT/HA200-DMPE. Other HA MW showed similar results [data not shown].
cellular uptake and the cytotoxic activity of the previously
prepared CNT/HA-DMPE, MDA-MB-231 and A2780 cells
were chosen as CD44+ and CD44− cells, respectively. For
these studies, fluorophore-labeled conjugates (f-HA-DMPE)
were used; the cellular uptake of CNTs and CNT/f-HA-
DMPE at increasing HA MW was quantitatively evaluated
by flow cytometry in the CD44+ and CD44− cell lines
(Figure 9).
In MDA-MB-231 (CD44+) cells, the CNTs uptake was
significantly increased over time and increasing HA MW. In
A2780 (CD44−) cells, a significant increase in CNT/f-HA-DMPE
cellular uptake was observed only after 24 h incubation, to
an extent independent from HA MW. Moreover, comparing
the iMFI ratio obtained in the two cell lines, the highest
value was observed with CNT/f-HA200-DMPE in MDA-MB-
231 cells and with CNT/f-HA51-DMPE in A2780 cells after
24 h incubation. The uptake level observed in the CD44− cell
line after 24 h was significantly lower than that observed in
the CD44+ cell line after the same incubation time. Likewise,
the levels reached in the CD44+ cell line after just 3 h
incubation were similar to that in the CD44− cell line after 24
h incubation.
These results are consistent with the idea that MDA-MB-
231 cells uptake CNT/f-HA-DMPE through the CD44 mediated
endocytosis pathway, highlighting their potential use as an
efficient approach for tumor-targeting treatments. Moreover,
in A2780 cells, aspecific mechanisms over receptor mediated-
pathways can have a role in the CNT/f-HA-DMPE uptake.
Similar results were also obtained by us evaluating the cellular
FIGURE 8 | Release of DOX from DOX/CNT/HA-DMPE at pH 7.4 and 5.5, as
measured at 37◦C over a 72 h period.
uptake of HA decorated carbon nano-onions by confocal live-cell
imaging (d’Amora et al., 2020).
Effects on Cell Proliferation
The in vitro cytotoxicity of the different preparations was
evaluated onMDAMB231 (CD44+) and A2780 (CD44−) cells at
three different incubation times; 24 (Figures 10, 11), 48 and 72 h.
On both cell lines, CNT/HA-DMPE of different HA MW
did not present significant effect on cell proliferation, while
DOX showed a marked difference in activity (IC50 0.5µM on
MDA-MB- 231 and 0.032µM on A2780 cell lines). A linear
increase of cytotoxicity was observed by increasing incubation
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FIGURE 9 | Cytofluorimetric cellular uptake; MDA-MB-231 and A2780 cells were incubated with CNTs and CNT/f-HA-DMPE of increasing HA MW (6.4, 17, 51, 200,
and 1,500 kDa) at the same concentration (10µg/mL) for 3 and 24 h and fluorescence was evaluated on FL-1 channel (λex: 488 nm, λem: 530 nm). Statistical
significance vs. CNTs: *p < 0.05 **p < 0.01, ***p < 0.001.
FIGURE 10 | Viability of the MDA-MB-231 (CD44+) cell line when treated with various formulations at different concentrations for 24 h. Cell viability was determined
using the sulforhodamine B (SRB) assay as previously described in material and methods section.
FIGURE 11 | Viability of the A2780 (CD44−) cell line when treated with various formulations at different concentrations for 24 h. Cell viability was determined using the
sulforhodamine B (SRB) assay as previously described in material and methods section.
time (higher for A2780 with 1 log decrease from 24 to 48 h).
Thus, the comparison of the cytotoxic activity reported in
Figures 10, 11 represents a 24 h incubation time. On target
cells (MDA-MB-231), the DOX/CNT/HA200-DMPE displayed
higher cytotoxicity, comparable to DOX, while both lower and
higher HA MW seemed to release the drug less efficiently.
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Increasing incubation time reduced this difference (data
not shown).
Due to their scarce water dispersibility, pristine CNTs cannot
be tested on cell lines. For this reason, the 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene
glycol)-2000] conjugate (PL-PEG) was employed to suspend
DOX/CNTs (DOX/CNT/PL-PEG) following a procedure
described elsewhere (Liu et al., 2009). On A2780 cells, no
significant difference between PEG or HA decorated CNTs has
been observed. On the contrary, on CD44+ cells, a significative
difference was observed, which appeared more evident in
comparison to DOX/CNT/HA200-DMPE, confirming the
cytofluorimetric results about the involvement of the HA
receptor in the cellular uptake, and consequent, cytotoxicity in
CD44+ cells.
CONCLUSION
In this study, a small library of HA-DMPE conjugates was
prepared using HA of different MW (6.4, 17, 51, 200, and
1,500 kDa). These were non-covalently functionalized onto
CNTs, which were further loaded with DOX. TGA, ZP, UV-
Vis absorption and fluorescence spectroscopy confirmed
the DOX loading and the HA-DMPE coating of CNTs.
Moreover, due to the HA coating, the nanostructures
were easily dispersed and stable in water and biological
media. The data obtained by the cellular uptake and cell
proliferation experiments indicated that CNT/HA200-
DMPE manifested the best active targeting ability among
all the conjugates. Drug release studies also suggested an
endogenous pH-responsive mode for site-specific drug release
which is of utmost importance for therapeutic applications
in tumors.
Altogether, the results suggest the possible use of our
conjugate, HA-DMPE, for an easy approach to improve the use
of CNTs for diagnostic and therapeutic purposes.
Of all the CNT-based drug delivery systems prepared
in this study, DOX/CNT/HA200-DMPE proved to be the
most viable nanocarrier. The underlying material, CNT/HA200-
DMPE, showed good biocompatibility, was easy to prepare,
and was highly dispersible in water and biological media.
Furthermore, biological studies confirmed that the system
possessed good targetability toward CD44 overexpressing cells.
The nanocarrier, DOX/CNT/HA200-DMPE, also possesses a
“smart release” feature, as identified through drug release studies.
The release of DOX has been found to be endogenously
stimulated at acidic pH, meaning that the DOX/CNT/HA200-
DMPE nanocarrier can selectively deliver the drug to tumor
cells, whilst avoiding premature drug release in tissues at
physiological pH.
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